Pharma stocks us biosecure act. This has increased the interest from big pharma in Indian companies. Sep 10, 2024 · Pharma stocks saw a significant uptick in early trading after the US House of Representatives passed the Biosecure Act, which aims to bolster the pharmaceutical supply chain and encourage domestic drug production. Sep 10, 2024 · The US House of Representatives on Monday passed the BIOSECURE Act by 306 votes to 81, which will prevent drug companies from doing business with certain Chinese biotechs within eight years. Sep 5, 2024 · CDMO stocks in focus as US House votes on Biosecure Act next week; Divi's Lab, among others to benefit, says expert The Biosecure Act may favour Indian CDMOs by limiting US partnerships with . -based biopharmas alike have speculated on what the legislation could mean for the life sciences industry. Laurus Labs, for example, has observed the beginning of vendor diversification and an uptick in late-phase Oct 7, 2024 · On 9 September the US House of Representatives passed the draft of the Biosecure Act, which aims to prohibit US pharma companies from doing business with five Chinese drugmakers over the next Aug 16, 2024 · The US Biosecure Act aims to decouple its supply chains from China, presenting a huge opportunity for India’s pharma industry The United States (US) is set to pass the Biosecure Act—an act that will impact the global biotechnology and pharmaceutical industries, ideally positioning India to dominate the landscape. S. Sep 10, 2024 · The US Biosecure Act aims to prohibit US drugmakers from engaging in business with five Chinese companies after eight years. 3 days ago · The revised US Biosecure Act is returning for discussion in Congress, reviving debates around biotechnology security and the role of foreign firms in America’s health ecosystem. Aug 28, 2024 · The Biosecure Act has led larger multinational corporations to cautiously explore ways to diversify their supplier base. Jul 31, 2024 · The BIOSECURE Act’s prohibition on doing business with China-based companies may have implications for biotech and biopharma markets on both sides of the Pacific. Jul 16, 2024 · The US Biosecure Act, if passed, is set to create substantial opportunities for Indian contract development and manufacturing organisations (CDMOs), according to pharmaceutical analysts. In this Sep 20, 2024 · On September 9, 2024, the US House of Representatives voted to pass the bill titled the BIOSECURE Act (the Act), which lists several Chinese companies in the pharmaceutical supply chain. The Act will prohibit American companies from contracting or doing business with certain listed biotechnology providers as a means of ‘protecting American personal health and genetic information’, as well Sep 6, 2024 · Aditya Khemka: I think the Biosecure Act will benefit a lot of Indian pharma companies who actually do business with global innovators. What Is the Biosecure Act? The proposed US law is designed to safeguard biotech and health data. The legislation is intended to protect US national security and prevent companies of high potential risk from Oct 4, 2024 · Since the introduction of the BIOSECURE Act in January, named companies and U. Jul 17, 2024 · In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act, which intends to prevent Chinese biotechs and manufacturers from accessing US funding and collaborating with pharma companies. It may also benefit those API manufacturers who do business with global generic pharma companies. Investors reacted positively to the news, with major pharmaceutical companies showing gains in the market. qfxj gzo pzfv nene otblpyi vgwbd bunhsc awnhf fqovez gbiym